These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 434713)

  • 1. [Abnormalities of fibrin formation in benign viral hepatitis (author's transl)].
    Thabaut A; Laverdant C; Durosoir JL; Cristau P; Essioux J; Molinié C
    Ann Med Interne (Paris); 1979; 130(1):35-8. PubMed ID: 434713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anomalies of fibrin formation in benign viral hepatitis].
    Thabaut A; Laverdant C; Durosoir JL; Cristau P; Essioux H; Molinie C
    Med Chir Dig; 1978; 7(7):555-7. PubMed ID: 755141
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coagulation factors during the development of common viral hepatitis].
    Thabaut A; Laverdant Ch; Durosoir JL; Voinesson A; Cristau F; Essioux H; Molinie Cl; Allard P; Roue R
    Ann Med Interne (Paris); 1975; 126(8-9):639-48. PubMed ID: 1217772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation.
    von Felten A; Straub PW; Frick PG
    N Engl J Med; 1969 Feb; 280(8):405-9. PubMed ID: 4303132
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reliability of tests for fibrinogen (fibrin) degradation products in plasma with thrombin coagulase, reptilase and thrombin clotting time (author's transl)].
    Wenzel E; Holzhüter H; Muschietti F; Angelkort B; Ochs HG; Pusztai-Markos S; Nowak H; Stürner H
    Dtsch Med Wochenschr; 1974 Apr; 99(15):746-56. PubMed ID: 4858105
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen and dysfibrinogenemia.
    Morse EE
    Ann Clin Lab Sci; 1980; 10(4):351-5. PubMed ID: 7447388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood coagulation abnormalities associated with envenoming by Trimeresurus albolabris in Hong Kong.
    Chan JC; Kwok MM; Cockram CS; Prematilleke MN; Tomlinson B; Critchley JA
    Singapore Med J; 1993 Apr; 34(2):145-7. PubMed ID: 8266156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule.
    Gralnick HR; Givelber H; Abrams E
    N Engl J Med; 1978 Aug; 299(5):221-6. PubMed ID: 207986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary dysfibrinogenaemia. Study of a family (author's transl)].
    Voinnesson A; Salaün M
    Sem Hop; 1979 Oct 8-15; 55(33-34):1507-12. PubMed ID: 229560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M; Baba M; Morimoto K; Nakamikawa C
    J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dysfibrinogenemia. A new case: dysfibrinogenemia Giessen III (author's transl)].
    Matthias FR; Krause WH; Ganssert S; Mueller K; Lasch HG
    Klin Wochenschr; 1977 Jun; 55(11):539-43. PubMed ID: 881774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The rapid determination of fibrin and fibrinogen split products with a bedside thrombin coagulase time test in obstetric coagulopathies (author's transl)].
    Kastendieck E; Barthels M
    Geburtshilfe Frauenheilkd; 1974 Sep; 34(9):758-62. PubMed ID: 4437565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
    Klingemann HG; Brunswig D; Liehr H
    Z Gastroenterol; 1978 Sep; 16(9):564-73. PubMed ID: 706517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired fibrin polymerization in viral hepatitis. Report of a case: probable identity of the inhibitor with beta2-microglobulin.
    Hammerschmidt DE; Moldow CF
    J Lab Clin Med; 1978 Dec; 92(6):1002-8. PubMed ID: 216757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acquired dysfibrinogenemia in a child in the course of a liver disease].
    Maak B; Meyer M; Dietze H
    Monatsschr Kinderheilkd; 1990 Aug; 138(8):446-50. PubMed ID: 2215508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Marburg a new genetic variant of fibrinogen.
    Fuchs G; Egbring R; Havemann K
    Blut; 1977 Feb; 34(2):107-18. PubMed ID: 836966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinogen Quebec I and Quebec II: two new families of dysfibrinogenemia (author's transl)].
    Jobin F; Vu L; Delage JM
    Acta Haematol; 1978; 59(2):119-27. PubMed ID: 415477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coagulation disorders without hemorrhagic diathesis due to delayed aggregration of fibrin molecules].
    von Felten A; Duckert F; Frick P
    Schweiz Med Wochenschr; 1965 Oct; 95(43):1453-6. PubMed ID: 5880932
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital dysfibrinogenaemia. Two new cases (author's transl)].
    Amsellem M; Samama M; Conard J; Levyne S; Ohlgiesser C
    Nouv Presse Med; 1978 Nov; 7(41):3745-8. PubMed ID: 733523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.